TD Asset Management Inc

Position in GPCR — Structure Therapeutics Inc.

CIK 1056053 Toronto, A6

Position in GPCR

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$9,869,528

-$2,279,048 QoQ

Shares Held

204,762

+17.2% QoQ

Ownership

0.096%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. GPCR ranks #28 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	350,923	$271,137,146
2	VRTX	Vertex Pharmaceuticals Inc / Ma	228,195	$101,898,194
3	ALNY	Alnylam Pharmaceuticals, Inc.	281,848	$93,255,047
4	HALO	Halozyme Therapeutics, Inc.	1,168,666	$75,530,883
5	ARGX	Argenx SE	80,824	$59,021,726
6	ASND	Ascendis Pharma A/S	217,992	$49,861,310
7	IONS	Ionis Pharmaceuticals Inc	529,954	$39,794,245
8	RVMD	Revolution Medicines, Inc.	317,811	$30,907,119

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,869,528	204,762	+17.2%	Shares	Sole	2026-05-11
2025-12-31	$12,148,576	174,674	+384.0%	Shares	Sole	2026-02-10
2025-09-30	$1,010,408	36,086	-17.4%	Shares	Sole	2025-11-10
2025-06-30	$906,047	43,686	0.0%	Shares	Sole	2025-07-28
2025-03-31	$756,204	43,686	-50.8%	Shares	Sole	2025-05-07
2024-12-31	$2,410,479	88,882	-53.4%	Shares	Sole	2025-02-11
2024-09-30	$8,372,280	190,756	-9.8%	Shares	Sole	2024-11-01
2024-06-30	$8,309,139	211,590	+47.9%	Shares	Sole	2024-08-02
2024-03-31	$6,133,266	143,100	-9.0%	Shares	Sole	2024-05-08
2023-12-31	$6,409,836	157,258	+3.3%	Shares	Sole	2024-02-12
2023-09-30	$7,672,713	152,176	+109.3%	Shares	Sole	2023-10-27
2023-06-30	$3,022,513	72,709	+102.3%	Shares	Sole	2023-08-09
2023-03-31	$855,155	35,946	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.